On September 29th, Hengrui Pharmaceutica - Telegraph

B · Normal

On September 29th, Hengrui Pharmaceutical's H shares rose by more than 5%. The company signed a licensing agreement for the HRS-1596 project with Novo, with a potential total transaction value of up to US$2.6 billion.

medicine 🕐 2026-09-29 13:03

#medicine

← Back to Telegraph

Related telegraphs

[Shanghai RAAS responded to the acquisition of a CDMO factory: intending to supp 09-29 13:56 On September 28, the U.S. Food and Drug Administration (FDA) approved AbbVie’s J 09-28 20:01 [National Medical Insurance Administration: The continued procurement of oral me 09-28 17:20 [Hansoh Pharmaceutical responded to the withdrawal of the EU approval for Ametin 09-27 21:21 September 24th: Kobayashi Pharmaceutical is negotiating a US$3.2 billion privati 09-24 16:50 [InnoCare: A wholly-owned subsidiary signed a licensing agreement with Eli Lilly 09-24 12:07

Comments

No comments yet